Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Veröffentlicht/Copyright: 8. Mai 2009
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Use of biomarkers in heart disease

Standardisation of HbA1c

The power of networking

Personnalized health care – what it takes to be a leader

Integrated diagnostics – what do you think the next generation of healthcare will look like?

Biochips can save lives: cardiovascular disease

The future and importance of solution business

What is new on cardiac troponin?

Diagnostic performance and clinical value of holotranscobalamin, measured by the AxSYM Active-B12 assay, for vitamin B12 status

Directing the spotlight on renal disease

Automation solutions for laboratories in hospital networks

Beyond blood

Complementary role of serology and NAT in the diagnosis of viral hepatitis

New developments in prostate cancer management

Advances in clinical diagnostics by LC-MS/MS – novel diagnostic kits & quality controls and their value for routine clinical laboratories

The clinical value of serum HER-2/neu in breast cancer patients – an update

The urinary sediment: an update

Roche Diagnostics new offering for high volume laboratories. cobas 8000 modular analyzer: a new dimension of efficiency and productivity

Prevention and early detection of gynecological cancer

Current and future perspectives with cardiac biomarkers

Managing urinary tract infection (UTI) – still a challenge?

Advances in reproductive endocrinology and high-risk pregnancy testing

Biochips to advance research

Recent advances in the management of free light chain disease

The appropriate application of Lean

Haemolysis: causes, affects, prevalence, measurement & solutions in pathology

Pentra 400® evaluation for therapeutic drug monitoring and drug abuse testing

Learn how VITROS® Diagnostic Systems help you optimize productivity in your laboratory by using objective metrics

Vitamin D osteoporosis and beyond

Published Online: 2009-05-08
Published in Print: 2009-06-01

©2009 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Committees
  2. Committees
  3. Plenary Lecture Abstracts
  4. EUSPM Symposium Abstracts
  5. Symposium Abstracts
  6. Industry Sponsored Workshop Abstracts
  7. Poster Abstracts
  8. Ageing
  9. Ageing
  10. Allergy
  11. Allergy
  12. Autoimmune diseases
  13. Autoimmune diseases
  14. Blood banking and haemovigilance
  15. Blood banking and haemovigilance
  16. Bone disease and vitamin D
  17. Bone disease and vitamin D
  18. Coronary artery disease/ischemic damage
  19. Coronary artery disease/ischemic damage
  20. Cardiovascular disease: Heart failure/hypertension
  21. Cardiovascular disease: Heart failure/hypertension
  22. Cancer/tumour markers
  23. Cancer/tumour markers
  24. Clinical importance of laboratory testing
  25. Clinical importance of laboratory testing
  26. Critical care testing
  27. Critical care testing
  28. Diabetes mellitus
  29. Diabetes mellitus
  30. Fertility
  31. Fertility
  32. Genetics
  33. Genetics
  34. Haematology
  35. Haematology
  36. Haemostasis
  37. Haemostasis
  38. Immunology
  39. Immunology
  40. Immunoassays
  41. Immunoassays
  42. Infectious diseases
  43. Infectious diseases
  44. Information technology
  45. Information technology
  46. Inherited and acquired metabolic diseases
  47. Inherited and acquired metabolic diseases
  48. Iron metabolism/haemochromatosis
  49. Iron metabolism/haemochromatosis
  50. Kidney disease
  51. Kidney disease
  52. Lipids and lipoproteins
  53. Lipids and lipoproteins
  54. Liver and gastrointestinal diseases
  55. Liver and gastrointestinal diseases
  56. Mass spectrometry
  57. Mass spectrometry
  58. Metabolic syndrome(s)
  59. Metabolic syndrome(s)
  60. Metabolomics
  61. Metabolomics
  62. Molecular diagnostics
  63. Molecular diagnostics
  64. Neonatology
  65. Neonatology
  66. Neurodegenerative diseases
  67. Neurodegenerative diseases
  68. Nutrition
  69. Nutrition
  70. Paediatric clinical chemistry
  71. Paediatric clinical chemistry
  72. Pharmacogenetics/pharmacogenomics
  73. Pharmacogenetics/pharmacogenomics
  74. Point of care testing
  75. Point of care testing
  76. Proteins and proteomics
  77. Proteins and proteomics
  78. Quality assessment
  79. Quality assessment
  80. Reproductive endocrinology
  81. Reproductive endocrinology
  82. Rheumatology
  83. Rheumatology
  84. Stroke
  85. Stroke
  86. Technology, instrumentation and methods
  87. Technology, instrumentation and methods
  88. Thyroid function
  89. Thyroid function
  90. Traceability and standardisation
  91. Traceability and standardisation
  92. Miscellaneous
  93. Miscellaneous
  94. Author Index
  95. Author Index
Heruntergeladen am 5.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.384/html
Button zum nach oben scrollen